MetLife Investment Management’s Arteris AIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Sell
16,582
-369
-2% -$5.85K ﹤0.01% 2063
2025
Q4
$263K Hold
16,951
﹤0.01% 2143
2025
Q3
$171K Hold
16,951
﹤0.01% 2406
2025
Q2
$162K Hold
16,951
﹤0.01% 2295
2025
Q1
$117K Hold
16,951
﹤0.01% 2454
2024
Q4
$173K Hold
16,951
﹤0.01% 2369
2024
Q3
$131K Buy
16,951
+9,551
+129% +$73.7K ﹤0.01% 2513
2024
Q2
$55.6K Buy
+7,400
New +$56.3K ﹤0.01% 2742

Other funds holding AIP

MetLife Investment Management's AIP Position: Q1 2026 in Review

MetLife Investment Management reduced its Arteris (AIP) stake by 2.2% in Q1 2026, selling an estimated $5.85K and leaving 16,582 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

MetLife Investment Management first reported a position in AIP in Q2 2024 and has held it in 8 quarters since. 152 funds tracked by Wall St. Rank hold AIP as of Q1 2026.

  • MetLife Investment Management held 16,582 shares of Arteris worth $273K as of Q1 2026.
  • MetLife Investment Management sold 369 Arteris shares in Q1 2026, an estimated $5.85K.
  • Arteris made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2063 holding.
  • MetLife Investment Management first reported a position in Arteris in Q2 2024 and has held it in 8 quarters since.
  • 152 funds tracked by Wall St. Rank held Arteris as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.